Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Fasching

Showing results (61-70 of 810) with videos related to

Pageof 81
Sort By:
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 26, 2019
Awareness of breast cancer incidence and risk factors among healthy women in Germany: an update after 10 yearsUwe G Poehls, Carolin C Hack, Marius Wunderle, et al.
Breast Cancer Research : BCR|January 17, 2013
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screeningVera Kloten, Birte Becker, Kirsten Winner, et al.
Reviews on Recent Clinical Trials|February 4, 2017
Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast CancerHans-Christian Kolberg, Gyoergy Loevey, Leyla Akpolat-Basci, et al.
Geburtshilfe Und Frauenheilkunde|February 12, 2024
Identification of Patients with Early HR+ HER2- Breast Cancer at High Risk of RecurrencePeter A Fasching, Hans Kreipe, Lucia Del Mastro, et al.
Reproductive Biomedicine Online|September 8, 2021
Comparison of methods for isolation and quantification of circulating cell-free DNA from patients with endometriosisHanna Huebner, Hannah Lubrich, Simon Blum, et al.
Breast Cancer Research : BCR|August 17, 2012
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT studyVolkmar Müller, Sabine Riethdorf, Brigitte Rack, et al.
Geburtshilfe Und Frauenheilkunde|January 16, 2026
Validation of the Questionnaire for the Structured Assessment of the Use of Complementary Medicine Methods and Procedures in Patients from the S3 Guideline Complementary Medicine in Oncology and Practical Use of it in Patients with Gynecological CancerKatharina Seitz, Anna-Katharin Theuser, Carolin C Hack, et al.
Geburtshilfe Und Frauenheilkunde|April 20, 2019
Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support CausalityMarlena S Fejzo, Peter A Fasching, Michael O Schneider, et al.
Breast Care (Basel, Switzerland)|September 30, 2010
Are Certified Breast Centers Cost-Effective?Matthias W Beckmann, Mayada R Bani, Christian R Loehberg, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 19, 2016
Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapyHans-Christian Kolberg, Gyoergy Loevey, Leyla Akpolat-Basci, et al.
Pageof 81

Showing results (61-70 of 810) with videos related to

Sort By:
Pageof 81
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 26, 2019
Awareness of breast cancer incidence and risk factors among healthy women in Germany: an update after 10 yearsUwe G Poehls, Carolin C Hack, Marius Wunderle, et al.
Breast Cancer Research : BCR|January 17, 2013
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screeningVera Kloten, Birte Becker, Kirsten Winner, et al.
Reviews on Recent Clinical Trials|February 4, 2017
Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast CancerHans-Christian Kolberg, Gyoergy Loevey, Leyla Akpolat-Basci, et al.
Geburtshilfe Und Frauenheilkunde|February 12, 2024
Identification of Patients with Early HR+ HER2- Breast Cancer at High Risk of RecurrencePeter A Fasching, Hans Kreipe, Lucia Del Mastro, et al.
Reproductive Biomedicine Online|September 8, 2021
Comparison of methods for isolation and quantification of circulating cell-free DNA from patients with endometriosisHanna Huebner, Hannah Lubrich, Simon Blum, et al.
Breast Cancer Research : BCR|August 17, 2012
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT studyVolkmar Müller, Sabine Riethdorf, Brigitte Rack, et al.
Geburtshilfe Und Frauenheilkunde|January 16, 2026
Validation of the Questionnaire for the Structured Assessment of the Use of Complementary Medicine Methods and Procedures in Patients from the S3 Guideline Complementary Medicine in Oncology and Practical Use of it in Patients with Gynecological CancerKatharina Seitz, Anna-Katharin Theuser, Carolin C Hack, et al.
Geburtshilfe Und Frauenheilkunde|April 20, 2019
Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support CausalityMarlena S Fejzo, Peter A Fasching, Michael O Schneider, et al.
Breast Care (Basel, Switzerland)|September 30, 2010
Are Certified Breast Centers Cost-Effective?Matthias W Beckmann, Mayada R Bani, Christian R Loehberg, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 19, 2016
Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapyHans-Christian Kolberg, Gyoergy Loevey, Leyla Akpolat-Basci, et al.
Pageof 81